These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 24531117)

  • 21. Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas.
    Wizigmann-Voos S; Breier G; Risau W; Plate KH
    Cancer Res; 1995 Mar; 55(6):1358-64. PubMed ID: 7533661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Central nervous system hemangioblastomas, endolymphatic sac tumors, and von Hippel-Lindau disease.
    Richard S; David P; Marsot-Dupuch K; Giraud S; Béroud C; Resche F
    Neurosurg Rev; 2000 Mar; 23(1):1-22; discussion 23-4. PubMed ID: 10809480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular pathology of eyes with von Hippel-Lindau (VHL) Disease: a review.
    Chan CC; Collins AB; Chew EY
    Retina; 2007 Jan; 27(1):1-7. PubMed ID: 17218907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Propranolol reduces viability and induces apoptosis in hemangioblastoma cells from von Hippel-Lindau patients.
    Albiñana V; Villar Gómez de Las Heras K; Serrano-Heras G; Segura T; Perona-Moratalla AB; Mota-Pérez M; de Campos JM; Botella LM
    Orphanet J Rare Dis; 2015 Sep; 10():118. PubMed ID: 26394686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Notch receptor and effector expression in von Hippel-Lindau disease-associated central nervous system hemangioblastomas.
    Merrill MJ; Edwards NA; Lonser RR
    J Neurosurg; 2011 Sep; 115(3):512-7. PubMed ID: 21663414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ocular clusterin expression in von Hippel-Lindau disease.
    Zhou M; Shen D; Head JE; Chew EY; Chévez-Barrios P; Green WR; Chan CC
    Mol Vis; 2007 Nov; 13():2129-36. PubMed ID: 18079682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular genetic analysis of the von Hippel-Lindau disease tumor suppressor gene in familial and sporadic cerebellar hemangioblastomas.
    Tse JY; Wong JH; Lo KW; Poon WS; Huang DP; Ng HK
    Am J Clin Pathol; 1997 Apr; 107(4):459-66. PubMed ID: 9124215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extraneuraxial hemangioblastoma: A clinicopathologic study of 10 cases with molecular analysis of the VHL gene.
    Muscarella LA; Bisceglia M; Galliani CA; Zidar N; Ben-Dor DJ; Pasquinelli G; la Torre A; Sparaneo A; Fanburg-Smith JC; Lamovec J; Michal M; Bacchi CE
    Pathol Res Pract; 2018 Aug; 214(8):1156-1165. PubMed ID: 29941223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coexpression of erythropoietin and vascular endothelial growth factor in nervous system tumors associated with von Hippel-Lindau tumor suppressor gene loss of function.
    Krieg M; Marti HH; Plate KH
    Blood; 1998 Nov; 92(9):3388-93. PubMed ID: 9787178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathological study of vascular endothelial growth factor (VEGF), p53, and proliferative potential in familial von Hippel-Lindau disease and sporadic hemangioblastomas.
    Miyagami M; Katayama Y; Nakamura S
    Brain Tumor Pathol; 2000; 17(3):111-20. PubMed ID: 11310918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stereotactic radiosurgery for intracranial hemangioblastomas: a retrospective international outcome study.
    Kano H; Shuto T; Iwai Y; Sheehan J; Yamamoto M; McBride HL; Sato M; Serizawa T; Yomo S; Moriki A; Kohda Y; Young B; Suzuki S; Kenai H; Duma C; Kikuchi Y; Mathieu D; Akabane A; Nagano O; Kondziolka D; Lunsford LD
    J Neurosurg; 2015 Jun; 122(6):1469-78. PubMed ID: 25816088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of von Hippel-Lindau disease-associated CNS lesions.
    Wind JJ; Lonser RR
    Expert Rev Neurother; 2011 Oct; 11(10):1433-41. PubMed ID: 21955200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Essentials and pitfalls in the treatment of CNS hemangioblastomas and von Hippel-Lindau disease.
    Gläsker S; Klingler JH; Müller K; Würtenberger C; Hader C; Zentner J; Neumann HP; Velthoven VV
    Cent Eur Neurosurg; 2010 May; 71(2):80-7. PubMed ID: 20229452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Somatostatin receptor 2A expression in von Hippel-Lindau-related hemangioblastomas.
    Ahmad S; Muhlebner A; Snijders TJ; de Leng WW; Seute T; van Leeuwaarde RS
    Cancer; 2024 Oct; 130(20):3473-3479. PubMed ID: 38824656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pregnancy-related hemangioblastoma progression and complications in von Hippel-Lindau disease.
    Frantzen C; Kruizinga RC; van Asselt SJ; Zonnenberg BA; Lenders JW; de Herder WW; Walenkamp AM; Giles RH; Hes FJ; Sluiter WJ; van Pampus MG; Links TP
    Neurology; 2012 Aug; 79(8):793-6. PubMed ID: 22875085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease.
    Conway JE; Chou D; Clatterbuck RE; Brem H; Long DM; Rigamonti D
    Neurosurgery; 2001 Jan; 48(1):55-62; discussion 62-3. PubMed ID: 11152361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of stem cells markers in ocular hemangioblastoma associated with von Hippel-Lindau (VHL) disease.
    Chan CC; Chew EY; Shen D; Hackett J; Zhuang Z
    Mol Vis; 2005 Sep; 11():697-704. PubMed ID: 16163267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth rate and fate of untreated hemangioblastomas: clinical assessment of the experience of a single institution.
    Byun J; Yoo HJ; Kim JH; Kim YH; Cho YH; Hong SH; Kim CJ
    J Neurooncol; 2019 Aug; 144(1):147-154. PubMed ID: 31201685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of Hemangioblast Proteins in von Hippel-Lindau Disease Related Tumors.
    Vergauwen E; Forsyth R; Vortmeyer A; Gläsker S
    Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37174017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Von hippel-lindau disease: a genetic and clinical review.
    Haddad NM; Cavallerano JD; Silva PS
    Semin Ophthalmol; 2013; 28(5-6):377-86. PubMed ID: 24138046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.